focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Hiya CTSFO! ice to see you too :-) Was it you mentioned RUA around 2 weeks ago 'elsewhere'? If it wasn't you then there's another person at least on both BBs.
I've had RUA for a long time, since it was over £1. They say waiting for risk to reduce and then investing is a good policy and perhaps the riskiest times will be behind us, sooner rather than later, though I have lost track a little with one thing and another.
Thanks Goldielocks. It's for wyn to reply if wyn wishes but I do like to read his posts.
You wrote 'you hardly interact with any other boards.' so I had to check and I know see wyn posted on ABDX, Harland and Wolf, WOSG, and HE1. I had missed some of them on HE1 and HARL and will take a look, try to find them.
So, thank you.
Where else have you posted in the last month? I can only see AVCT. Even I've posted on more.. I might post on RUA right now.
'Whatever they were told they thought it was a good bet...our shorter has been around shorting for years and they will have k own that.'
I'm not sure I follow tbh Bella. The last time I checked there was one shorter and a relatively new one to AVCT, not Bronte or Jupiter. I hope shorters aren't getting inside info alongside the IIs.
'It's the cold facts of the money side that have caught him out.'
Are you implying that the money side is ok Bella? If his decisions (who knows how much was him / the Bod) had gone well then AVCT wouldn't be at 43p would they. That is a cold fact.
We just don't know why he went do we Wyn. Whatever they'd said (more time with family; more time in family house; ill-health; wants to be pure scientist again) people would have been sceptical, so why say anything.
Surely he just couldn't have made up a lot of the things he said (65% size reduction) without others colluding or at least seeing that he had a point.. On the face of it one could argue that enthusiasm could lead to the 'pivotal' claim with justification. It's the cold facts of the money side that have caught him out. Maybe he had an Estelle Morris moment or had such a moment forced upon him.
I used to think that CC would want to provide good news (new broom and all that) quite quickly to show that things will be very different on her watch.
Now I think she wants a decent gap after AS's departure so that any news is definitely HER news and wasn't on the cusp of announcement anyway.
Funny how one can justify any position to fit the circumstances that prevail.
I've truncated the thread title to avoid accusations of a motive.
One crumb for me is that while GSA have taken their position Bronte and Jupiter, who have a history with AVCT going back to 2021 and who might have done quite well, seem not to have a short atm (not above 0.49% anyway). They have steered clear this time, and as we all know, there is a tendency to stick with a share one knows well.
Just read your Telegraph piece VS
(It's a bit like my daughter who is now suddenly confined to a wheelchair for a rather rare but hopefully temporary condition. People have started saying to us, with a smile, "shouldn't you be wearing a hat" which they wouldn't say to a standing teenager, and we haven't heard since they were in buggies. Discrimination?
Still, no offence taken by us.)
I think of this share rather like a new discovery of a painting that could be by.. Renoir, Michelangelo, Van Gogh, OR it could be a pastiche and only in the *style* of said artist.
The authenticated value will be multiple times the value of a painting by a nobody.
43.75 is the Un-authenticated value while the experts study the brush work.
Would be nice if they could crack on with the authentication.
Can't even recall what vote was quite about now but private investors managed to vote against – and by a margin – a proposal at Pharm2Farm / NNN so it is perfectly possible to reject a low offer when PIs hold a lot of the shares.
And while I am on the subject of dads at the school gate, another dad works with this company* and timeline is interesting. https://www.autolus.com/about-us/our-history/
They IPO'd on the Nasdaq in 2018. Their sp is a lot lower now.
*'Autolus is founded on advanced cell programming technology pioneered by Dr Martin Pule and was spun-out from University College London in 2014. Since its inception, the company has undergone rapid growth, systematically adding the capabilities and capital required to manufacture, develop and commercialise its programmed T cell product candidates.'
Market capitalisation: $1.09 bn
' The DX side with hindsight was always just an excuse to keep TX going until they proved it beyond doubt so they could spin it off.'
There's a dad at the school gate who works for a diagnostics company. He's on the financial side. (I did buy some shares in his PLC for a while as they seemed to be doing well, getting a bigger HQ etc.). Anyway, he is always very bullish on diagnostics due to advances investing technology and the ageing population which will use more and more testing as time passes.